Calendar

Week of Apr 24, 2023

Apr 28, 2023approval1201d agoVIGABATRIN — FDA approvalVIGABATRIN

Sponsor: CARNEGIE. Form: TABLET. Route: ORAL

Apr 28, 2023approval1201d agoSOGROYA (SOMAPACITAN-BECO) — FDA approvalsomatriptan albumin bound LA

Sponsor: NOVO NORDISK INC. Form: SOLUTION. Route: SUBCUTANEOUS

Apr 28, 2023approval1201d agoLIBTAYO (CEMIPLIMAB-RWLC) — FDA approvalcemiplimab

Sponsor: REGENERON PHARMACEUTICALS. Form: INJECTABLE. Route: INTRAVENOUS

Apr 28, 2023approval1201d agoLIBTAYO (CEMIPLIMAB-RWLC) — FDA approvalcemiplimab

Sponsor: REGENERON PHARMACEUTICALS. Form: INJECTABLE. Route: INTRAVENOUS

Apr 28, 2023approval1201d agoUZEDY (RISPERIDONE) — FDA approvalDelpor Inc

Sponsor: TEVA. Form: SUSPENSION, EXTENDED RELEASE. Route: SUBCUTANEOUS

Apr 28, 2023approval1201d agoVEKLURY (REMDESIVIR) — FDA approvalremdesivir

Sponsor: GILEAD SCIENCES INC. Form: SOLUTION. Route: INTRAVENOUS

May 1, 2023approval1198d agoDALFAMPRIDINE — FDA approvaldalfampridine ER

Sponsor: ACCORD HLTHCARE. Form: TABLET, EXTENDED RELEASE. Route: ORAL

May 1, 2023approval

May 8, 2023approval1191d agoCEFAZOLIN SODIUM — FDA approvalSamson Medical Technologies LLC

Sponsor: HQ SPCLT PHARMA. Form: POWDER. Route: INTRAVENOUS

May 8, 2023approval

May 15, 2023approval1184d agoINREBIC (FEDRATINIB HYDROCHLORIDE) — FDA approvalfedratinib

Sponsor: BRISTOL-MYERS. Form: CAPSULE. Route: ORAL

May 18, 2023approval

May 22, 2023approval1177d agoVIGPODER (VIGABATRIN) — FDA approvalPyros Pharmaceuticals Inc.

Sponsor: PYROS PHARMS. Form: FOR SOLUTION. Route: ORAL

May 22, 2023approval

← prev

page 1 of 497